Between poor patient adherence and the inherent IOP peaks and troughs associated with eye drop-managed glaucoma, sustained-release medications are greatly needed, a presenter at the virtual OSN New York meeting said.
About half of all patients taking eye drops struggle with adherence, especially with midday doses, and about two-thirds do not administer the drops correctly, Sarah H. Van Tassel, MD, said.
Furthermore, laser and surgical therapies are not appropriate for all patients because of prior glaucoma surgery, angle anatomy not amenable to selective laser trabeculoplasty, patient
Uncategorized